MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).
Triple negative breast cancer: Pitfalls and progress
TAS-119 is a Selective and Orally Active Aurora A Inhibitor
A novel small molecule STAT3 inhibitor SLSI-1216 suppresses
The novel STAT3 inhibitor WZ-2-033 causes regression of human
CFI-402257 is a Highly Selective and Orally Active Inhibitor of Mps1/TTK
Avitinib is an Irreversible, Mutant-Selective EGFR Inhibitor
PDF) STAT3 suppresses transcription of proapoptotic genes in
LY294002, a PI3K Inhibitor, is an Autophagy and Apoptosis Inducer
AC-73 is a Specific and Orally Active CD147 Dimerization Inhibitor
UZH1a is a Selective METTL3 Inhibitor
Biomedicines, Free Full-Text
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast